AYURF
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Dec 26 closing price
Capitalization
3.56M
HNSPF
Price
$2.11
Change
+$0.11 (+5.50%)
Updated
Jan 14 closing price
Capitalization
9.59B
Ad is loading...

AYURF vs HNSPF

Header iconAYURF vs HNSPF Comparison
Open Charts AYURF vs HNSPFBanner chart's image
AYURCANN
Price$0.02
Change-$0.00 (-0.00%)
Volume$2K
Capitalization3.56M
Hansoh Pharmaceutical Group
Price$2.11
Change+$0.11 (+5.50%)
Volume$100
Capitalization9.59B
AYURF vs HNSPF Comparison Chart
Loading...
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYURF vs. HNSPF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYURF is a Hold and HNSPF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AYURF: $0.02 vs. HNSPF: $2.11)
Brand notoriety: AYURF and HNSPF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AYURF: 23% vs. HNSPF: 23%
Market capitalization -- AYURF: $3.56M vs. HNSPF: $9.59B
AYURF [@Pharmaceuticals: Other] is valued at $3.56M. HNSPF’s [@Pharmaceuticals: Other] market capitalization is $9.59B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYURF’s FA Score shows that 0 FA rating(s) are green whileHNSPF’s FA Score has 1 green FA rating(s).

  • AYURF’s FA Score: 0 green, 5 red.
  • HNSPF’s FA Score: 1 green, 4 red.
According to our system of comparison, HNSPF is a better buy in the long-term than AYURF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYURF’s TA Score shows that 2 TA indicator(s) are bullish while HNSPF’s TA Score has 1 bullish TA indicator(s).

  • AYURF’s TA Score: 2 bullish, 2 bearish.
  • HNSPF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, HNSPF is a better buy in the short-term than AYURF.

Price Growth

AYURF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while HNSPF (@Pharmaceuticals: Other) price change was +5.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($9.59B) has a higher market cap than AYURF($3.56M). HNSPF has higher P/E ratio than AYURF: HNSPF (30.21) vs AYURF (6.50). AYURF YTD gains are higher at: 0.000 vs. HNSPF (-1.088). HNSPF has higher annual earnings (EBITDA): 3.62B vs. AYURF (-4.24M). HNSPF has more cash in the bank: 20.9B vs. AYURF (1.44M). AYURF has less debt than HNSPF: AYURF (234K) vs HNSPF (4.13B). HNSPF has higher revenues than AYURF: HNSPF (9.97B) vs AYURF (10.2M).
AYURFHNSPFAYURF / HNSPF
Capitalization3.56M9.59B0%
EBITDA-4.24M3.62B-0%
Gain YTD0.000-1.088-
P/E Ratio6.5030.2122%
Revenue10.2M9.97B0%
Total Cash1.44M20.9B0%
Total Debt234K4.13B0%
TECHNICAL ANALYSIS
Technical Analysis
AYURFHNSPF
RSI
ODDS (%)
Bullish Trend 11 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 11 days ago
50%
Momentum
ODDS (%)
Bearish Trend 11 days ago
89%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
64%
N/A
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
66%
Bullish Trend 11 days ago
7%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RPTTX48.040.32
+0.67%
T. Rowe Price Diversified Mid Cap Gr I
LZIOX16.360.09
+0.55%
Lazard International Equity Open
FFTYX16.050.07
+0.44%
AB Sustainable US Thematic Advisor
VMVIX65.440.22
+0.34%
Vanguard Mid-Cap Value Index Investor
MRIMX23.340.07
+0.30%
Victory Integrity Mid-Cap Value R6

AYURF and

Correlation & Price change

A.I.dvisor tells us that AYURF and PRFX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYURF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYURF
1D Price
Change %
AYURF100%
N/A
PRFX - AYURF
21%
Poorly correlated
-7.08%
HNSPF - AYURF
11%
Poorly correlated
N/A
STEK - AYURF
5%
Poorly correlated
+10.59%
BFRI - AYURF
3%
Poorly correlated
+2.80%
HLBBF - AYURF
-0%
Poorly correlated
-8.94%
More

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
+0.95%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
-5.39%
IXHL - HNSPF
5%
Poorly correlated
+4.32%
BFRI - HNSPF
4%
Poorly correlated
+2.80%
More